Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, parallel-group, vehicle-controlled, dose-finding study to
investigate the pharmacodynamics and the safety of three dosages of CD07805/47 topical gel
(0.07%, 0.18%, and 0.50%), after a single application in subjects with a clinical diagnosis
of stable moderate to severe erythematotelangiectatic rosacea. Subjects will be randomized in
a 1:1:1:1 ratio to receive either one of three CD07805/47 topical gel concentrations (0.07%,
0.18%, or 0.50%) or Vehicle Gel. All subjects will be treated with a single application (once
daily dosing for one day) of study medication.